Trial Profile
PROphylaxis for ThromboEmbolism in Critical care Trial (PROTECT) pilot study
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 26 Sep 2022
Price :
$35
*
At a glance
- Drugs Dalteparin sodium (Primary) ; Heparin
- Indications Deep vein thrombosis; Thromboembolism
- Focus Therapeutic Use
- Acronyms PROTECT